Highline Wealth Partners’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.63K Buy
102
+15
+17% +$1.21K ﹤0.01% 671
2026
Q1
$6.15K Buy
87
+31
+55% +$2.32K ﹤0.01% 661
2025
Q4
$4.42K Sell
56
-11,348
-100% -$898K ﹤0.01% 591
2025
Q3
$939K Sell
11,404
-1
-0% -$79 0.25% 56
2025
Q2
$917K Buy
11,405
+36
+0.3% +$2.78K 0.27% 55
2025
Q1
$913K Buy
11,369
+2
+0% +$166 0.31% 58
2024
Q4
$931K Buy
11,367
+18
+0.2% +$1.5K 0.3% 56
2024
Q3
$936K Sell
11,349
-43
-0.4% -$3.21K 0.31% 57
2024
Q2
$800K Buy
11,392
+57
+0.5% +$4.07K 0.3% 58
2024
Q1
$840K Hold
11,335
0.34% 59
2023
Q4
$750K Hold
11,335
0.36% 63
2023
Q3
$713K Hold
11,335
0.44% 53
2023
Q2
$641K Hold
11,335
0.4% 60
2023
Q1
$657K Hold
11,335
0.45% 55
2022
Q4
$820K Hold
11,335
0.61% 49
2022
Q3
$689K Buy
+11,335
New +$724K 0.56% 46

Other funds holding MET

Highline Wealth Partners's MET Position: Q2 2026 in Review

Highline Wealth Partners increased its MetLife (MET) stake by 17% in Q2 2026, buying an estimated $1.21K and bringing the position to 102 shares worth $8.63K. The position accounts for ﹤0.01% of the portfolio, ranked #671.

Highline Wealth Partners first reported a position in MET in Q3 2022 and has held it in 16 quarters since. The position peaked at $939K in Q3 2025. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Highline Wealth Partners held 102 shares of MetLife worth $8.63K as of Q2 2026.
  • Highline Wealth Partners bought 15 MetLife shares in Q2 2026, an estimated $1.21K.
  • MetLife made up ﹤0.01% of Highline Wealth Partners's portfolio in Q2 2026, its #671 holding.
  • Highline Wealth Partners first reported a position in MetLife in Q3 2022 and has held it in 16 quarters since.
  • Highline Wealth Partners's MetLife position peaked at $939K in Q3 2025.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.